tribal cannabis programs received no mention in the Department of Justice Final Order issued in April 2026 that moved FDA-approved and state-regulated medical marijuana products to Schedule III of the Controlled Substances Act. The Order also ended a stalled administrative hearing process and launched an expedited DEA hearing set for June 29–July 15, 2026. Public debate has focused on federal tax impacts and a new, faster DEA registration path for state-licensed medical cannabis businesses; the Order’s silence on Tribal programs creates concrete regulatory, commercial and tax uncertainties.
What the Order did – The DOJ reclassified FDA-approved and state-regulated medical cannabis products to Schedule III. – DOJ terminated the pending administrative hearing schedule and opened an expedited comment and registration window from June 29 to July 15, 2026. – The Order links DEA registrant authority to compliance with state law and state regulatory systems that meet specified enforcement priorities.
Immediate market effects for state businesses – Federal tax treatment: Moving eligible medical products to Schedule III means Section 280E, which denies business deductions for Schedule I and II drug trafficking, may no longer apply to those products for registered entities. Analysts estimate some state medical operators could reduce taxable income deductions denials for qualifying products, altering tax liabilities that previously raised effective federal tax rates on cannabis businesses by several percentage points. – DEA registration and supply chain: The Order establishes a DEA registration pathway that limits registrants to sourcing through the DEA wholesaler chain. The current DEA wholesaler price referenced in public materials is $113 per kilogram. Registered businesses will generally be permitted to transact only with other DEA registrants.
Where Tribal operations intersect with the new regime – Omission of Tribes: The Order contains no provisions that explicitly recognize Tribal cannabis regulatory programs (including those run independently by Tribal nations or operated under state-Tribal compacts, such as in Minnesota and Michigan). That omission has two immediate consequences: 1) Access risk: Because DEA-registered entities must source from DEA-authorized wholesalers and transact only with other registrants, Tribal producers that cannot obtain DEA registration could be excluded from supply agreements with newly registered state licensees. This raises the probability that Tribal cultivation and processing operations will face lost market access to state-licensed retail lines that choose to register. 2) Commercial opportunity: Some state operators may opt not to register under the new DEA pathway. In states with hybrid medical/adult-use markets, Tribes could supply those unregistered operators under existing state-compact arrangements, filling local supply gaps. That dynamic will depend on state compact terms, existing compliance documentation, and state enforcement priorities.
Interstate commerce and Tribal options – The Order does not authorize interstate cannabis commerce for registrants; it conditions registrant authority on state law. Currently no U.S. state permits interstate cannabis sales. – Tribal nations that want to position themselves for future cross-border trade can amend Tribal codes to permit commerce between Tribal jurisdictions. If and when the DEA expands registration eligibility to Tribal entities, Tribes that have adopted inter-tribal commerce provisions could act as first movers to serve multiple Tribal markets.
Tax status and remaining liabilities – Federal income tax: IRS guidance issued in December 2025 reaffirmed that Tribal governments and their wholly owned chartered corporations are generally exempt from federal income tax. That status remains in force for Tribal entities acting in governmental capacity. – State taxes and 280E analogs: Where Tribes operate under state compacts or state law frameworks, state-level taxes and 280E-style disallowances could still apply. State tax codes and enforcement approaches vary; Tribes should review compact terms and state tax guidance to estimate net tax exposure under the new Schedule III treatment.
Regulatory compliance benchmarks – The DOJ Order borrows language used previously in Department memos tied to enforcement priorities. Although the Wilkinson Memo was rescinded, its enforcement priorities (public safety, diversion control, product testing, track-and-trace, licensing and monitoring) are echoed in the Order’s standards for regulatory adequacy. – For Tribes seeking future DEA registration or to reduce enforcement risk, aligning Tribal cannabis codes with those enforcement priorities will have measurable value. Specific actions include: implementing full seed-to-sale track-and-trace, standardizing product testing that meets or exceeds state requirements, establishing robust licensing and inspection systems, and documenting diversion prevention procedures.
Practical steps for Tribal governments and operators – Audit current codes and compliance programs against the DOJ’s stated regulatory priorities and the Wilkinson Memo standards. – Review compact terms with states (examples: Minnesota, Michigan) to clarify tax liabilities, licensing reciprocity and supply chains. – Evaluate commercial arrangements with state operators that may not register; draft contracts that address compliance, indemnities and payment terms given current registration gaps. – Consider drafting or amending Tribal codes to allow commerce between Tribal jurisdictions and to set clear standards for product testing and recordkeeping in anticipation of potential future DEA registration.
Bottom line The April 2026 DOJ Final Order creates a new regulatory framework for FDA-approved and state-regulated medical cannabis but does not address Tribal cannabis programs. That omission creates measurable risks—restricted market access to DEA-registered supply chains priced at roughly $113/kg wholesale—and measurable openings for Tribes that can supply unregistered state operators or adopt inter‑Tribal commerce rules. Tribal governments and Tribal businesses should quantify tax exposure under state compacts, align codes with stated enforcement priorities, and prepare documentation that could support future DEA registration eligibility.
